Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.

Venture Capital

Versant Ventures

Brad Bolzon

Rami Hannoush

Nigel Sheail

Shane Mulligan

Lawrence Klein

Mehmet Badur

Stephan Kontos

Rich Van Doren

Elizabeth Alcamo

Clare Ozawa

Guido Magni

Markus Enzelberger

Alex Mayweg

Max Eisenberg

Joel Drewry

Carlo Rizzuto

Tom Woiwode

Jerel Davis

Brian Busser

Angela McDonald

Tom Frohlich

Steve Edelson

Robin Praeger

Rachel Lane

Peter Emtage

Peppi Prasit

Markus Warmuth

Marcelo Bigal

Versant Ventures' Board of Directors includes Christine Mathews.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Versant Ventures

Leadership Team

CEO and Executive Team